Surface-Modified Lyotropic Crystalline Nanoconstructs Bearing Doxorubicin and Buparvaquone Target Sigma Receptors through pH-Sensitive Charge Conversion to Improve Breast Cancer Therapy

Singh, Neha; Marwaha, Disha; Gautam, Shalini; Rai, Nikhil; Tiwari, Pratiksha; Sharma, Madhu; Shukla, Ravi Prakash; Mugale, Madhav Nilakanth; Kumar, Akhilesh; Mishra, Prabhat Ranjan

doi:10.1021/acs.biomac.3c00795

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Surface-Modified Lyotropic Crystalline Nanoconstructs Bearing Doxorubicin and Buparvaquone Target Sigma Receptors through pH-Sensitive Charge Conversion to Improve Breast Cancer Therapy

Cited by 9 publications

References 55 publications

Introduction to Biomaterial-Inspired Nanomedicines

Introduction to Biomaterial-Inspired Nanomedicines

Targeting of Tumor Microenvironment Through Nano-Biomaterial-Based Chemotherapy

Extracellular vesicles-powered immunotherapy: Unleashing the potential for safer and more effective cancer treatment

Contact Info

Product

Resources

About